These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15077035)

  • 1. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation.
    Laux G; Mytilineos J; Opelz G
    Transplantation; 2004 Mar; 77(6):902-7. PubMed ID: 15077035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
    Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
    Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.
    Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM
    Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants.
    Laux G; Mansmann U; Deufel A; Opelz G; Mytilineos J
    Transplantation; 2003 May; 75(9):1527-32. PubMed ID: 12792509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.
    Duquesnoy RJ
    Hum Immunol; 2002 May; 63(5):339-52. PubMed ID: 11975978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort.
    Haririan A; Fagoaga O; Daneshvar H; Morawski K; Sillix DH; El-Amm JM; West MS; Garnick J; Migdal SD; Gruber SA; Nehlsen-Cannarella S
    Clin Transplant; 2006; 20(2):226-33. PubMed ID: 16640531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants.
    Tran TH; Döhler B; Heinold A; Scherer S; Ruhenstroth A; Opelz G
    Transplantation; 2011 Aug; 92(4):419-25. PubMed ID: 21743387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strength of HLA-A, HLA-B, and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Collaborative Transplant Study.
    Opelz G
    Transpl Int; 1992; 5 Suppl 1():S621-4. PubMed ID: 14628741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation.
    Kosmoliaptsis V; Sharples LD; Chaudhry A; Johnson RJ; Fuggle SV; Halsall DJ; Bradley JA; Taylor CJ
    Hum Immunol; 2010 Sep; 71(9):851-6. PubMed ID: 20538027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the 1998 UK National Allocation Scheme for deceased heartbeating donor kidneys.
    Fuggle SV; Johnson RJ; Bradley JA; Rudge CJ;
    Transplantation; 2010 Feb; 89(4):372-8. PubMed ID: 20177337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HLA matching for CREG antigens in Europe.
    Wujciak T; Opelz G
    Transplantation; 1999 Oct; 68(8):1097-9. PubMed ID: 10551635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.